Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Saved in:
| Title: | Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection. |
|---|---|
| Authors: | Dalai SC; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Dines JN; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Snyder TM; Adaptive Biotechnologies, Seattle, Washington, USA., Gittelman RM; Adaptive Biotechnologies, Seattle, Washington, USA., Eerkes T; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA., Vaney P; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA., Howard S; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA., Akers K; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Skewis L; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Monteforte A; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Witte PR; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Wolf C; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Nesse H; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Herndon M; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Qadeer J; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Duffy S; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Svejnoha E; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Taromino C; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Kaplan IM; T-Detect Product Management, Adaptive Biotechnologies, Seattle, Washington, USA., Alsobrook J; Molecular Lab Management, Adaptive Biotechnologies, Seattle, Washington, USA., Manley T; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Baldo L; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Dec 19; Vol. 75 (12), pp. 2079-2087. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciac353 |
